← Back to Clinical Trials
Recruiting NCT06511362

NCT06511362 Comparative Effects of Perturbation and Functional Stabilization Training on Patellofemoral Pain Syndrome

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06511362
Status Recruiting
Phase
Sponsor Riphah International University
Condition Patellofemoral Pain Syndrome
Study Type INTERVENTIONAL
Enrollment 26 participants
Start Date 2023-02-15
Primary Completion 2024-07-15

Eligibility & Interventions

Sex Female only
Min Age 15 Years
Max Age 30 Years
Study Type INTERVENTIONAL
Interventions
Functional stabilization trainingperturbation exercises

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 26 participants in total. It began in 2023-02-15 with a primary completion date of 2024-07-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The main objective of this study is to determine the comparative effects of perturbation and functional stabilization training on pain, balance, and performance in athletes with patellofemoral pain syndrome(PFPS). Patellofemoral pain syndrome is one of the well known causes of anterior knee joint pain. Proximal and distal joint muscle imbalances are the most predisposing factors in knee pain especially knee cap. Anterior knee pain Increase during flexion of the knee, i.e., jumping, running, squatting and descending stairs. PFPS have a crucial impact on balance and functional activities, particularly for young athletes under the age 40. Individuals with PFPS manifest abnormalities in the dynamic and kinematic balance of the lower extremity. Participants between the age of 18-30 with knee pain and have difficulty performing the activities. Perturbation training is the part of the neuromuscular training program include the balancing activities that test the balance during the rehabilitation program. Functional stabilization training is used to improve the muscle control and strength. This particular program focuses on improving balance and determining the effect of training on prformance and balance of athletes with PFPS.

Eligibility Criteria

Inclusion Criteria: 1. Anterior knee pain. 2. Age between 15 to 30. 3. Pain between 3 to 10 on NPRS. Exclusion Criteria: 1. patellar fracture. 2. Intra-articular pathology( ligamental and meniscal injury of the knee). 3. Knee surgery 4. Fracture of hip, knee, shin bone and foot 5. Vestibular and visual disorders

Contact & Investigator

Central Contact

AISHA SIDDIQA, MS-DPT

✉ ayeshamalik5905@gmail.com

📞 03180068205

Principal Investigator

Amna Shahid, T-DPT

PRINCIPAL INVESTIGATOR

Riphah inernational university.

Frequently Asked Questions

Who can join the NCT06511362 clinical trial?

This trial is open to female participants only, aged 15 Years or older, up to 30 Years, studying Patellofemoral Pain Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06511362 currently recruiting?

Yes, NCT06511362 is actively recruiting participants. Contact the research team at ayeshamalik5905@gmail.com for enrollment information.

Where is the NCT06511362 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT06511362 clinical trial?

NCT06511362 is sponsored by Riphah International University. The principal investigator is Amna Shahid, T-DPT at Riphah inernational university.. The trial plans to enroll 26 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology